Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
중증 COVID-19 성인에 대한 렘데시비르: 무작위, 이중 맹검, 위약 대조, 다기관 시험
Randomized Controlled Trial
[키워드] Academy
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adult patients
Adverse
adverse event
adverse events
Analysis
animal models
antiviral drug
arterial oxygen partial pressure
assigned
Beijing
breath
China
Chinese
clinical benefits
Clinical improvement
clinical status
concomitant use
confirmation
coronavirus
coronavirus disease
Coronavirus disease 2019
Corticosteroids
COVID-19
defined
development
discharged
double-blind
effective
Eligible patients
Emergency
enrolled
enrolment
event
faster
followed by
fractional inspired oxygen
GS-5734
hazard ratio
hospital
human coronaviruses
in vitro
inhibit
inhibitory effect
Inhibitory effects
intention-to-treat
interferons
Intravenous remdesivir
ITT
ITT population
laboratory-confirmed SARS-CoV-2 infection
less
Lopinavir
Lopinavir-ritonavir
Medical Science
Middle East
Middle East respiratory syndrome
Middle East respiratory syndrome Coronavirus
multicentre
nucleoside
one patient
Ordinal Scale
oxygen
oxygen partial pressure
oxygen saturation
partial pressure
pathogenic
Patient
Placebo
placebo group
placebo recipients
placebo-controlled
Pneumonia
primary analysis
primary endpoint
Program
randomisation
randomised
Randomly
receiving
recipient
reduction in
Registered
Remdesivir
reported
research and development
respiratory
respiratory syndrome coronavirus
Ritonavir
room air
safety analysis
SARS-CoV-1
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 replication
Science
severe acute respiratory syndrome Coronavirus
severe coronavirus disease
severe COVID-19
statistically significant
symptom duration
symptom onset
technology
the placebo group
those receiving placebo
treated
Treatment
treatment group
Trial
Volume
was done
[DOI] 10.1016/S0140-6736(20)31022-9 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1016/S0140-6736(20)31022-9 PMC 바로가기 [Article Type] Randomized Controlled Trial